EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Patient burden of chemosensory dysfunction and long COVID

Joachim Skovgaard Hansen, Max Rohde, Alexander Wieck Fjældstad

Danish Medical Journal · 2016-06 · 1-8

DOI: 10.61409/a01260014 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Danish Medical Journal, 2016-06. Verfasst von Joachim Skovgaard Hansen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Aarhus University Hospital. Hauptthemen laut MEDLINE: COVID-19, Olfaction Disorders, Quality of Life, Taste Disorders. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION. Chemosensory dysfunction (CD), particularly olfactory and gustatory dysfunction, is a common symptom of SARS-CoV-2 infection. While often transient, some patients develop persistent dysfunction. The long-term relationship between persistent CD, long COVID (LC) and quality of life (QoL) remains unclear. This study aimed to evaluate CD recovery four years after infection and its association with LC symptoms and QoL. METHODS. In this prospective cohort study, 356 individuals with sudden CD during the COVID-19 pandemic completed a questionnaire four years after symptom onset. The survey assessed CD recovery, LC symptoms and QoL using validated self-report items. Outcomes were compared between participants with recovered versus persistent CD. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. RESULTS. Only 43% reported full recovery of CD after four years. Persistent dysfunction was most common among participants aged 45-59 years (68%). Participants with persistent CD were significantly more likely to report LC symptoms, particularly fatigue (OR = 4.33), memory difficulties (OR = 3.30) and insomnia (OR = 3.39), each affecting more than 30% of this group. QoL scores indicated a greater impact on physical than emotional well-being. CONCLUSIONS. A substantial proportion of respondents continued to experience CD and other LC symptoms four years after infection. These findings highlight the need for long-term clinical awareness and further research on post-viral CD. FUNDING. None. TRIAL REGISTRATION. Not relevant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Olfaction DisordersQuality of LifeTaste DisordersAdultAgedFemaleHumansMaleMiddle AgedFatiguePandemicsPost-Acute COVID-19 SyndromeProspective StudiesSARS-CoV-2Surveys and QuestionnairesSymptom Burden

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Aarhus University Hospital.
  • Research Unit for ORL - Head and Neck Surgery and Audiology, Odense University Hospital.
  • Faculty of Health Sciences, Department of Clinical Research, University of Southern Denmark.
  • Flavour Institute, Department of Clinical Medicine, Aarhus University, Denmark.

Zitieren

APA

Hansen, J. S., Rohde, M., & Fjældstad, A. W. (2016). Patient burden of chemosensory dysfunction and long COVID. Danish Medical Journal, 1-8. https://doi.org/10.61409/a01260014

Vancouver

Hansen JS, Rohde M, Fjældstad AW. Patient burden of chemosensory dysfunction and long COVID. Danish Medical Journal. 2016:1-8. doi:10.61409/a01260014

BibTeX
@article{Hansen2016,
  author = {Hansen, Joachim Skovgaard and Rohde, Max and Fjældstad, Alexander Wieck},
  title = {Patient burden of chemosensory dysfunction and long COVID},
  journal = {Danish Medical Journal},
  year = {2016},
  pages = {1--8},
  doi = {10.61409/a01260014}
}
Kostenlos starten →